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Nuclear receptors (NRs) are a superfamily of transcription factors regulated by the direct binding of endogenous, dietary, clinical, and xenobiotic ligands, as well as by cellular 
signaling pathways. To orchestrate programs of gene expression in specific tissues, NRs interact with a large, disparate class of molecules known as coregulators, which either 
potentiate (coactivators) or suppress (corepressors) expression of NR target genes. In previous SnapShots, Nuclear Receptors I and Nuclear Receptors II, we described the 
major functions of the NRs, including genes they target and diseases associated with their abnormal activities.
In this SnapShot, we present information about the coregulators of NRs. Coregulators integrate diverse signals in the cell, including those from NRs and other pathways, 
and then mediate a co-ordinated transcriptional response to these afferent signals. Reflecting this biology, coregulators are organized into multicomponent and multifunctional 
protein complexes. The terms “coactivator” and “corepressor” are context specific because the specific tissue, cell, and promoter influence the function of a given coregulator.
The table here describes the major functions of selected coregulators and diseases associated with their abnormal activity. The name of each coregulator is given as: Familiar 
Symbol/HGNC symbol (Other common names). In addition, the table lists NRs with which the coregulator has been shown to interact physically or functionally. Similar lists are 
provided for interactions with NR coregulators and other proteins.
Additional information about NR coregulators is available at the Nuclear Receptor Signaling Atlas (NURSA) Molecule Pages website (http://www.nursa.org) and in the refer-
ences below. Specific literature on diseases associated with coregulators is at the Diseases and Phenotypes section of the NURSA Molecule Pages, whereas information about 
the coregulators’ interactions with NRs and other transcription factors is at the Interactions section of the NURSA Molecule Pages. The ordering of coregulators in the table is 
based on visits to the NURSA Molecule Pages from May 2009–May 2010.
Abbreviations
bHLH, basic-helix-loop-helix; CAPER, coactivator of activating protein-1 and estrogen receptors; CC1, coiled-coil 1; CNS, central nervous system; DBD, DNA-binding domain; 
ERE, estrogen response element; GHMP, galacto-, homoserine, mevalonate, and phosphomevalonate kinase; HAT, histone acetyltransferase; NA, not available; NURD, nucleo-
some remodeling and histone deacetylase; PAS, Per, Arnt, Sim domain; PHD, Plant Homeo Domain; PP-binding, Phosphopantetheine attachment site; RNP-1, RNA-binding 
motif 1; SANT, switching-defective protein 3 (Swi3), adaptor 2 (Ada2), nuclear receptor corepressor (N-CoR), transcription factor (TF)IIIB’; TAZ, Transcription Adaptor putative 
Zinc finger.
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